Evidence map›Paper›PMID 40099353›Full record

ArticleDermatology reports2025

Cutting-edge insights: line-field confocal optical coherence tomography and 5% cyclosporine for early lichen sclerosus treatment.

Caterina Mariarosaria Giorgio, Vittorio Tancredi, Gaetano Licata, Elvira Moscarella, Giuseppe Argenziano, Elisabetta Fulgione, Graziella Babino, Paolino Franzese, Eugenia Veronica Di Brizzi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Caterina Mariarosaria GiorgioDermatology Unit, University of Campania, Naples.ORCID 0009-0003-2148-8914
Vittorio TancrediDermatology Unit, University of Campania, Naples.ORCID 0009-0009-4276-0028
Gaetano LicataDermatology Unit, San Antonio Abate Hospital, Trapani.
Elvira MoscarellaDermatology Unit, University of Campania, Naples.
Giuseppe ArgenzianoDermatology Unit, University of Campania, Naples.ORCID 0000-0003-1413-8214
Elisabetta FulgioneDermatology Unit, University of Campania, Naples.ORCID 0009-0004-2635-8489
Graziella BabinoDermatology Unit, Department of Health Sciences, University of Basilicata, Potenza.ORCID 0000-0002-5121-1743
Paolino FranzeseDermatology Unit, University of Campania, Naples.ORCID 0009-0006-4190-6193
Eugenia Veronica Di BrizziDermatology Unit, University of Campania, Naples.ORCID 0000-0002-0278-2443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dear Editor, Atrophic lichen sclerosus (ALS) is a chronic inflammatory dermatosis with significant morbidity, primarily affecting the genital area. The disease is often misdiagnosed or underdiagnosed, resulting in delayed treatment and progression to atrophic stages and permanent scars. While corticosteroids remain the first-line treatment, their long-term use may lead to adverse effects such as skin atrophy, prompting the need for alternative therapies. [...].

Identifiers

PMID40099353
PMCPMC12679068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.